Trocars market Size was valued at USD 0.5 billion in 2022 and is projected to grow from USD 0.53 Billion in 2023 to USD 0.81 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.30% during the forecast period (2023 - 2030). The increasing prevalence of disorders will increase the number of laparoscopic surgeries performed in lockstep, which is the key market driver enhancing market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Increased prevalence of infections and smaller incisions lead to increased demand for treatments involving trocars. Possible trocar-induced problems such as vascular injury, intestinal injury, subcutaneous emphysema, air embolism, and lack of access to the abdominal cavity, these problems hamper the growth of the trocar market CAGR.
The increasing number of cases, innovation and improvement in medical procedures, Careful competence of clinicians and evolution of laparoscopy techniques are the factors influencing the growth of the trocar market in various applications. A shortage of qualified professionals, rising costs of laparoscopic medical procedures, and difficult access to clinics in the local market are factors inhibiting growth. The rise in gastrointestinal and liver disease has increased interest in common medical procedures that affect growth. Rising disease cases are the leading cause of death and help the market develop further and increase Trocars market revenue.
Figure 1: Comparison of all hospitalized patients (n = 126) and hospitalized patients with infections (n = 60)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Technological advances are shaping the trocar market. Companies on the market are increasingly investing in improving the technology of their trocars, reducing their susceptibility to error and improving their procedures. For instance, in March 2022, the Dutch Eye Research Center (DORC), a Dutch-based manufacturer of automated interferometers and inspection equipment, introduced its EVA NEXUS. The launch of EVA NEXUS has brought numerous advances in surgical efficacy and efficiency, including his SmartIOP, which now integrates with his EquiPhaco technology to improve control in cataract surgery. It includes an innovative trocar cannula called EVA AVETA, a chamfered cannula for easy insertion, a laser-etched shaft for scleral retention, a push-connect connector, and a Hi-Flow infusion connector.
Based on the product, the Trocars market segmentation includes disposable trocars, reusable trocars, and reposable trocars. The disposable Trocars segment held the majority share in 2022 for the Trocars market revenue due to the rising popularity of laparoscopic surgery. This category is expected to dominate the market during the forecast period. In addition, the advantages they offer, reduced postoperative infections and ease of use, contribute to segment expansion.
The Trocars market segmentation includes bladeless, optical, blunt, and bladed based on tips. Hence, rising Tip options for Trocars positively impact market growth. The optical segment dominated the market in 2022 due to Detailed views of tissues and an increasing number of laparoscopic surgeries performed. The benefits of this product also include safe and rapid initial placement of the trocar, which may drive growth in this segment.
Figure 2: Trocars market by Tips, 2022 & 2030 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
By region, the study offers market insights into Asia-Pacific, Europe, North America, and Rest of the World. The North America Trocars market accounted for USD 0.22 billion in 2022 and is anticipated to exhibit a substantial CAGR growth during the study period, attributed to the increasing preference for laparoscopic surgery over open surgery and increasing competition among major market players in terms of product innovations are strengthening the North American market. The United States is the main source of revenue for the region. Growing awareness of the benefits of minimally invasive and laparoscopic surgeries and rising healthcare costs are driving the regional market's growth.
Further, the key countries studied in the market report are: The U.S, Canada, UK, Italy, Spain, Germany, France, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: TROCARS MARKET SHARE BY REGION 2022 (%)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe's Trocars market accounts for the second-largest market share due to a well-established healthcare system, rising healthcare costs, greater adoption of innovative techniques and MIS surgical procedures, increasing prevalence and incidence of many chronic diseases associated with an increasing proportion of the elderly population, and major market players in this region. Further, the Germany Trocars market held the largest market share, and the United Kingdom Trocars market was the fastest growing market in the European region
The Asia-Pacific Trocars Market is anticipated to increase at the fastest CAGR from 2023 to 2030 due to the untapped opportunities and the growing older population. Trocars are becoming more widely accepted in APAC countries due to rising medical costs and technological advances. Moreover, government initiatives also play an important role in the market's growth. For instance, China's Ministry of Health has initiated a training program for laparoscopic surgeons. Further, the China Trocars market held the largest market share, and the India Trocars market was the fastest growing market in the region
Trocars Key Market Players & Competitive Insights
Key market players are spending a large portion of money on research & development to increase their product lines, which will help the Trocars market grow even more. Market players are also taking several strategic initiatives to increase their worldwide footprint, with key market developments such as mergers and acquisitions, contractual agreements, increased investments, new product launches, and collaboration with other organizations. Competitors in the Trocars industry must expand their business footprint to survive in an increasingly competitive and rising market environment.
One of the manufacturers primary business strategies in the global Trocars industry is to help clients and increase the market sector by increasing investment in R&D to enhance solutions and services. In recent years, the Trocars industry has provided innovative solutions and reduced disruptions in the supply chain. The Trocars markets major players such as Johnson & Johnson Services Inc., Medtronic, The Cooper Companies Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, GENICON INC., Applied Medical Resources Corporation, Fannin Ltd, Olympus' medical, Laprosurgeand, and others are functioning on expanding the market demand by financing in research and development actions.
Fannin Ltd is a subsidiary of DCC PLC, a leading international sales, marketing and support service group and a constituent of the FTSE 100, DCC Vital specializes in the sales, marketing and distribution of a broad range of pharmaceuticals, medical, surgical and laboratory products to healthcare professionals and patients in the UK, Ireland and international markets. For instance, In December 2020, Fannin Ltd introduced the Espiner SuitORpass, the disposable suture passer and guide. Since the first report of hernia development at a trocar site after laparoscopy, many techniques and devices have been introduced into practice to minimize this risk.
Olympus' medical business leverages its innovative capabilities in medical technology, therapeutic interventions and precision manufacturing to enable medical professionals to deliver diagnostic, therapeutic and minimally invasive procedures to improve clinical outcomes and help patients by reducing costs and improving quality of life. For instance, in September 2022, Olympus announced the launch of the Guardenia contained extraction system. It can be deployed through a standard 12mm trocar, under pneumoperitoneum and with or without vision
Key Companies in the Trocars market include
Trocars Industry Developments
March 2021: Vernacare, UK-based infection prevention and hygiene product manufacturer, acquired Robinson Healthcare for an undisclosed amount. The acquisition continues Vernacare’s buy-and-build strategy and increases the Group’s turnover to $167.5 million (£120m) annually. Robinson Healthcare is a UK-based company that manufactures single-use surgical instruments such as trocars, injection-molded single-use sterile devices, and steel-polymer composite devices. Robinson Healthcare is a UK-based company that manufactures single-use surgical instruments such as trocars, injection-molded single-use sterile devices, and steel-polymer composite devices.
September 2022:AFS MEDICAL GmbH launched a new product in the trocars line, LEXION AP 50/30. Its main specifications are a entirely closed system, continuous tissue moistening caused by permanent Co2 heating, and constant pneumoperitoneum.
North America
Europe
Asia-Pacific
Rest of the World
Middle East
Africa
Latin America
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 0.5 billion |
| Market Size 2023 | USD 0.53 billion |
| Market Size 2030 | USD 0.81 billion |
| Compound Annual Growth Rate (CAGR) | 7.30% (2023-2030) |
| Base Year | 2022 |
| Market Forecast Period | 2023-2030 |
| Historical Data | 2018 & 2021 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Market Competitive Landscape, Growth Factors, Revenue Forecast, and Trends |
| Segments Covered | Product, Tips, Application, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and Rest of the World |
| Countries Covered | The U.S, Canada, UK, Italy, Germany, France, Spain, India, China, Japan, Australia, South Korea, and Brazil |
| Key Companies Profiled | Johnson & Johnson Services Inc., Medtronic, The Cooper Companies Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, GENICON INC., Applied Medical Resources Corporation, Fannin Ltd, Olympus' medical, and Laprosurgeand |
| Key Market Opportunities | Technology advancement is the primary factor driving the market growth |
| Key Market Dynamics | Increase in the prevalence of infections and minor cuts to fuel market growth |
Frequently Asked Questions (FAQ) :
The market size of global Trocars was valued at USD 0.5 Billion in 2022.
The global market is projected to grow at a CAGR of 7.30% during the forecast period, 2023-2030.
North America had the leading share of the global market
The key players in the market johnson & Johnson Services Inc., Medtronic, The Cooper Companies Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, GENICON INC., Applied Medical Resources Corporation, Fannin Ltd, Olympus Medical, Laprosurgeand, and others.
The disposable trocars category dominated the market in 2022.
The Optical Tip had the largest global market share.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
